BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Novartis Holds Steady as White House Nears Drug Pricing Deal
Novartis Holds Steady as White House Nears Drug Pricing Deal
BTCCSquare news:
Novartis AG shares traded flat at $135.31 amid reports of imminent WHITE House action on prescription drug pricing. The Swiss pharma giant, which derives over 40% of revenue from the US market, faces potential tariff relief and regulatory clarity under the proposed agreement.
Talks reportedly include Roche Holding AG, with an announcement expected as early as Friday. The development marks a strategic pivot for the TRUMP administration, which has prioritized reducing the gap between US and international drug prices since summer 2020.
Previous
EquiLend Invests in Digital Prime to Bridge TradFi and Tokenized Markets
Next
Silver Surpasses Google to Become Fourth-Largest Asset by Market Cap
